BioPharma

Topic	Replies	Views	Activity
Biopharma Catalyst (FDA Approvals & Data Read outs) Pre-Read: Biopharma/tech Education I would like to start a overview of Biopharma Catalysts, including FDA approvals and binary data read-outs. Focus will be on small to medium market cap companies. It will exclude FDA a…	1322	4900	June 8, 2024
About BioPharma	0	268	October 12, 2021
Remarks by President Biden on the Economy: “We finally beat Pharma” – Did we?	13	410	February 13, 2024
Healthcare 2030	4	124	October 3, 2023
Cybin (CYBN) – Long Term Play with key 2023 data catalyst (February 28, 2023)	11	474	September 18, 2023
NVCR - Novocure Ltd - Q1 2023 LUNAR Readout and JPM Healthcare Conference catalysts	8	342	August 28, 2023
VistaGen Therapeutics (VTGN) - Phase 2a data read out in Q1 2023	12	263	August 7, 2023
Acumen Pharmaceuticals (ABOS) - Alzheimer’s disease (AD) Phase 1 top-line data due in 3Q 2023	4	216	June 13, 2023
RAIN Oncology (Therapeutics) – Does it rain money? (Q2)	11	441	May 22, 2023
Krystal Biotech (KRYS) FDA Approval - B-VEC (GEM-3) – 2/17/2023 (High Risk)	9	292	May 19, 2023
IBRX - ImmunityBio - FDA Approval (May 23, 2023) / M&A Play	9	220	May 11, 2023
Cingulate (CING) - I have been told that i have ADHD, but i dont think i - hey look, a squirrel	7	236	May 9, 2023
Allogene Therapeutic (ALLO) - Phase 1 data update to be presented at ASCO 23 on June 3	1	180	April 30, 2023
ASLAN Pharmaceuticals (ASLN) - Upcoming Catalyst (early July) - Phase 2b TREK-AD trial to treat atopic dermatitis (AD)	5	500	April 28, 2023
$MCRB (McRib? a/k/a Seres Therapeutics Inc.) discussion	5	201	April 27, 2023
Cullinan Oncology (CGEM) – Phase 1 data due in mid-2023 for two Studies + Long-term Hold Opportunity	2	244	April 26, 2023
Reviva Pharmaceuticals (RVPH) - Brilaroxazine for Schizophrenia discussion , bullish	4	212	April 26, 2023
Vaccinex (VCNX) – Initial Phase 1b data read out in mid-2023 and topline results in 2024	5	308	April 25, 2023
Achieve Life Sciences (ACHV) – Phase 3 Topline results expected 2Q 2023 - smoking cessation and nicotine addiction	6	359	April 20, 2023
CTLT thread for Burrowing Owlet	2	224	April 18, 2023
Ensysce Biosciences - $ENSC - PF614-MPAR - Novel Opioid Designed to Prevent Abuse and Overdose	3	334	April 3, 2023
Non-alcoholic steatohepatitis (NASH) Catalysts: Viking Therapeutics (VKTX) and Madrigal Pharmaceuticals (MDGL)	3	316	March 28, 2023
AVDL discussion and competitors	51	1450	March 22, 2023
Inozyme Pharma (INZY) – Long Term Play with Q1 Catalysts (Thursday, Feb. 16, 2023 at 8 a.m. ET)	7	406	March 19, 2023
Roivant Sciences (ROIV) – multiple rich data catalysts in 2023 and 2024	5	308	March 15, 2023
InVivo Therapeutics Holdings (NVIV) - Binary Data Catalyst in Q1	1	233	March 9, 2023
Neurocrine Biosciences (NBIX)– FDA Approval (August 20) and data catalyst in 2023 (2h)	0	199	February 14, 2023
Oramed Pharmaceuticals (ORMP) – the Oral company - Data Catalyst (Phase 3) in January	1	228	January 12, 2023
TG Therapeutics Inc. (TGTX) - Ublituximab FDA Approval 28th Dec (HIGH RISK)	8	359	December 28, 2022
KYMR- Upcoming Catalyst - major binary events (Dec 2022)	3	171	December 14, 2022

Biopharma Catalyst (FDA Approvals & Data Read outs)

Pre-Read: Biopharma/tech Education I would like to start a overview of Biopharma Catalysts, including FDA approvals and binary data read-outs. Focus will be on small to medium market cap companies. It will exclude FDA a…